posted
I bought in at 8.25 a while ago, thinking it would bottom out their and eventually rise. Should i build up a bit more now that its around 7.80....or is their some signs that this company isnt doing to well and the stock is not gonna move for awhile. Newbie to the market so my DD skills are weak, in other words i dont trust em yet!
Posts: 24 | From: Sierra Vista, AZ | Registered: Feb 2004
| IP: Logged |
posted
Cray was feaured by Barron's last year to go to ?30$? as i recall---start there----super super computers are ESSENTIAL to make the next step in DATA analysis--we have been focusing on PC's for ten years and they are GGOOOOODD but now we have all the power at our finger tips that we need (until the next big software step comes)---the crays are necessary for crunching large chunks of data--Digital Eqpt. Corp.--once provided this service--they have been bought out--CRAY is still there----
it has not done what Barron's was predicting so see why.
posted
Took Glassman's advice to see why they didn't perform as they were predicted.... It appears that they have had less income than was estimated as well as the depressed situation of the market as a whole working against them. It would seem that they are starting to run in the black ink a little later than they thought, too. Now it appears as they have gotten the financials under control and some big news today of an acquisition also could bring this one up to a much higher price.
I am new to DD bigtime so as with any persons info...BE CAREFUL and x2 with mine.
If anyone sees something amiss with the above, I'd appreciate some (constructive) criticism.
Mucho luck
Posts: 72 | From: Seattle, WA | Registered: Feb 2004
| IP: Logged |
posted
I beleive that the future of biotech is DNA associated analysis---i am in good company on that belief--If you think the PC revolutin was big--well i don't want to get too ahead of the current game --my point is that super computers will become more valuable as we gather more DNA DATA---the relationships to explore on a single HUMAN genomic sequence are in the BILLIONS-add a couple dozen people into a comprehensive study and we are talking about some major computing requirements --we stil have some time to go before this is an investment issue but put the whole issue on your long range map---Human Genome Sciences just had some big insider SELLING. I beleive they had a few crays--but i could be wrong----
[This message has been edited by glassman (edited February 26, 2004).]
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
